Skip to main content
All lobbying filings

HIMS & HERS HEALTH, INC.

Lobbying for HIMS & HERS HEALTH, INC. · Telehealth services

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$270,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

S.3794 SAFE Drugs Act H.R.6509 SAFE Drugs Act Drug Enforcement Administration's special registrations for telemedicine and limited state telemedicine registrations Matters related to compounding, telehealth, and healthcare

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem